Suppr超能文献

通过石蜡免疫组织化学鉴别经典型霍奇金淋巴瘤、富于T细胞的B细胞淋巴瘤和副肉芽肿

Differential diagnosis between classic Hodgkin's lymphoma, T-cell-rich B-cell lymphoma, and paragranuloma by paraffin immunohistochemistry.

作者信息

Rüdiger T, Ott G, Ott M M, Müller-Deubert S M, Müller-Hermelink H K

机构信息

Department of Pathology, University of Würzburg, Germany.

出版信息

Am J Surg Pathol. 1998 Oct;22(10):1184-91. doi: 10.1097/00000478-199810000-00003.

Abstract

There are significant difficulties in the differential diagnosis of lymphomas at the interface between classic Hodgkin's lymphoma and both paragranuloma and T-cell-rich B-cell lymphoma as well as at the interface between T-cell-rich B-cell lymphoma and paragranuloma. We therefore investigated 197 cases (155 classic Hodgkin's lymphomas, 32 T-cell-rich B-cell lymphomas, and 10 paragranulomas) by paraffin immunohistochemistry. Special interest was given to cases with a B-cell phenotype of tumor cells. The reactive inflammatory infiltrate in both classic Hodgkin's lymphoma and T-cell-rich B-cell lymphoma was rich in TIA-1-positive cytolytic lymphocytes, and CD57-positive cells were rarely encountered. In contrast, in paragranuloma CD57-positive cells and small B-lymphocytes predominated the background infiltrate. The tumor cells in cases of classic Hodgkin's lymphoma were positive for CD30 in 95%, for CD15 in 75%, and for CD20 in 22%. Apart from this, vimentin was expressed in >95% of the cases. All cases of T-cell-rich B-cell lymphoma were negative for vimentin, CD30, and CD15. The reactivity of the tumor cells for CD30, CD15, CD20, and vimentin together with the background reactivity for CD57 and TIA-1 seem to reliably discriminate between the entities and should therefore help to increase the interobserver reproducibility of diagnoses in the gray zone around Hodgkin's lymphoma.

摘要

在经典型霍奇金淋巴瘤与副肉芽肿以及富于T细胞的B细胞淋巴瘤之间的交界区域,以及富于T细胞的B细胞淋巴瘤与副肉芽肿之间的交界区域,淋巴瘤的鉴别诊断存在重大困难。因此,我们采用石蜡免疫组织化学方法对197例病例(155例经典型霍奇金淋巴瘤、32例富于T细胞的B细胞淋巴瘤和10例副肉芽肿)进行了研究。对肿瘤细胞具有B细胞表型的病例给予了特别关注。经典型霍奇金淋巴瘤和富于T细胞的B细胞淋巴瘤中的反应性炎症浸润富含TIA-1阳性的细胞溶解性淋巴细胞,很少见到CD57阳性细胞。相比之下,在副肉芽肿中,CD57阳性细胞和小B淋巴细胞在背景浸润中占主导地位。经典型霍奇金淋巴瘤病例中的肿瘤细胞95% CD30阳性,75% CD15阳性,22% CD20阳性。除此之外,波形蛋白在>95%的病例中表达。所有富于T细胞的B细胞淋巴瘤病例波形蛋白、CD30和CD15均为阴性。肿瘤细胞对CD30、CD15、CD20和波形蛋白的反应性,以及对CD57和TIA-1的背景反应性似乎能够可靠地区分这些实体,因此有助于提高霍奇金淋巴瘤周围灰色地带诊断的观察者间可重复性。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验